Summary
To clarify the source of human urine EGF, we studied EGF renal clearance in 20 healthy, young adult subjects. Immunoreactive EGF was measured hourly in EDTA plasma, heparin plasma, serum and urine of 12 males and 8 females during a 3 h study period. Plasma and urine creatinine and creatinine clearance were measured and calculated hourly. Mean (and SEM) creatinine clearance was similar in males and females (118±12 vs 105±6 ml/min). EGF was not detectable in plasma, whereas relatively high levels were measured in serum (2.5±0.25 vs 1.5±0.18 ng/ml in males and females respectivelyp<0.05). Urine EGF excretion averaged 1641±233 ng/h in males and 1507±191 ng/h in females (p>0.05). A significant correlation was observed between urine creatinine and urine EGF concentrations in both male (r = 0.98,p<0.01) and female (r=0.94,p< 0.01) subjects. EGF immunoreactivity in urine and serum eluted from G-75 sephadex columns similarly to recombinant 6000 Mr hEGF. Urine excretion of EGF approximated 1.5 μg/h or 25 ng/mg creatine. The high concentrations of EGF found in urine in the face of non-detectable levels of EGF in plasma favor the hypothesis that EGF in urine is derived from kidney synthesis and secretion. The significant positive correlation between urine creatinine and urine EGF suggests a functional correlation between glomerular filtration and the process of tubular EGF excretion.
Similar content being viewed by others
Abbreviations
- EGF :
-
epidermal growth factor
- hEGF :
-
human epidermal growth factor
- IGF :
-
insulin-like growth factor
- TGF :
-
alpha transforming growth factor
- TGF :
-
beta transforming growth factor
- NGF :
-
nerve growth factor
- PDGF :
-
platelet derived growth factor
- CPDA :
-
citrate phosphate dextrose adenine buffer
- EDTA :
-
ethylenedinitrilotetraacetic acid
- PBS :
-
phosphate saline buffer
References
Assoian RK, Grotendorst GR, Miller DM, Sporn MB (1984) Cellular transformation by coordinated actions of three peptide growth factors from human platelets. Nature 309:804–806
Byyny RL, Orth DN, Cohen S (1972) Radioimmunoassay of epidermal growth factor. Endocrinology 90:1261
Catterton WZ, Escobedo MB, Saxon WR, Gray ME, Sundell HW, Stahlman MT (1979) Effect of epidermal growth factor on lung maturation in fetal rabbits. Pediatr Res 13:104–108
Cohen S (1962) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237:1555–1562
Cohen S, Carpenter G (1975) Human epidermal growth factor: Isolation and chemical and biological properties. Proc Natl Acad Sci USA 72:1317–1321
Cohen S, Taylor JM (1974) Epidermal growth factor: Chemical and biological characterization. Rec Prog Horm Res 30:533–550
Dailey GE, Kraus JW, Orth DN (1978) Homologous radioimmunoassay for human epidermal growth factor (urogastrone). J Clin Endocrinol Metab 46:929–936
Elder JB, Ganguli PC, Gillespie IE, Gerring L, Gregory H (1975) Effect of urogastrone on gastric secretion and plasma gastrin levels in normal subjects. Gut 16:887–893
Gerring ED, Gregory H (1974) Urogastrone. Prog Gastroenterol 67:739–743
Greenwood FC, Hunter WM, Glover JSP (1962) The preparation of131I labelled human growth factor of high specific radioactivity. Biochem J 89:114–123
Gregory H, Willshire IR (1975) The isolation of the urogastrones. Inhibitors of gastric acid secretion from human urine. Hoppe Seylers Z Physiol Chem 356:1765–1775
Hirata Y, Moore GW, Bertagna C, Orth DN (1980) Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man. J Clin Endocrinol Metab 50:440–444, 1980
Hirata Y, Orth DN (1979) Converison of high molecular weight epidermal growth factor (hEGF) urogastrone (UG) to low molecular weight hEGF/G by mouse EGF-associated arginine esterase. J Clin Endocrinol Metab 49:481–483
Hirata Y, Orth DN (1979) Epidermal growth factor (urogastrone) in human fluid: size heterogeneity. J Clin Endocrinol Metab 48:673–679
Kasselberg AG, Orth DN, Gray ME, Stallman MT (1985) Immunocytochemical localization of human epithelial growth factor/urogastrone in several human tissues. J Histochem Cytochem 33:315–322
Mattila AL, Pasternack A, Viinikka L, Perheentupa J (1986) Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease. J Clin Endocrinol Metab 62:1180–1183
Oka Y, Orth DN (1983) Human plasma epidermal growth factor/β-urogastrone is associated with blood platelets. J Clin Invest 72:249–259
Olsen PS, Nexo E, Paulsen SS, Hansen HG, Kirkegaard P (1984) Renal origin of rat urinary epidermal growth factor. Regul Pep 10:37–45
Perheentupa J, Lakshmanan J, Fisher DA (1985) Epidermal growth factor in mouse urine: non-blood origin, and increase by sialoadenectomy and T4 therapy. Acta Endocrinol 108:428–432
Perheentupa J, Lakshmanan J, Macaso T, Fisher DA (1984a) Growth hormone increases neonatal mouse urine epidermal growth factor. Acta Endocrinol 106:184–189
Perheentupa J, Lakshmanan J, Hoath SB, Fisher DA (1984b) Hormonal modulation of mouse plasma concentration of epidermal growth factor. Acta Endocrinol 107:571–576
Rall LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan JP (1985) Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313:228–231
Salido E, Barajas L, Lechago J, Laborde NP, Fisher DA (1986) Immunocytochemical localization of epidermal growth factor (EGF) in mouse kidney. J Histochem Cytochem 34:1155–1160
Sundell H, Serenius F, Barthe P, Friedman Z, Kanarek K, Escbedo M, Orth D, Stahlman M (1975) The effects of EGF on fetal lamb lung maturation. Pediatr Res 9:371
Starkey RH, Cohen S, Orth DN (1975) Epidermal growth factor: Identification of a new hormone in human urine. Science 189:800–802
Vaitukaitis J, Robbins JB, Nieschlag E (1971) A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol 33:988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Callegari, C., Laborde, N.P., Buenaflor, G. et al. The source of urinary epidermal growth factor in humans. Europ. J. Appl. Physiol. 58, 26–31 (1988). https://doi.org/10.1007/BF00636599
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00636599